The LONZA human recombinant insulin is produced according to cGMP and labeled "For Further Manufacturing"(FFM). GMP Products are intended for research or further manufacturing use only. They conform to cGMP manufacturing compliance expectations for medical devices, including 21 CFR Part 820 and ISO 13485. Do not use this product for direct therapeutic use in humans.
ProCHO and PowerCHO media do not contain significant amounts of insulin, which may be vital in some cases for protein production in CHO cells.
